Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Alar Pharmaceuticals Inc (6785) Financial Statements

Alar Pharmaceuticals Inc Financial Overview

Alar Pharmaceuticals Inc's market cap is currently NT$5.11B. The company's EPS TTM is NT$-1.09; its P/E ratio is -73.49; and it has a dividend yield of 0.12%. Alar Pharmaceuticals Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 2.75MNT$ 5.82MNT$ 469.27MNT$ 800.00KNT$ 0.00
Gross ProfitNT$ -2.73MNT$ 3.79MNT$ 469.27MNT$ 800.00KNT$ 0.00
Operating IncomeNT$ -167.80MNT$ -67.94MNT$ 385.53MNT$ -46.53MNT$ -93.30M
EBITDANT$ -74.02MNT$ 49.50MNT$ 394.52MNT$ -29.31MNT$ -60.85M
Net IncomeNT$ -79.68MNT$ 18.17MNT$ 382.62MNT$ -19.87MNT$ -64.23M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.30BNT$ 2.43BNT$ 895.99MNT$ 486.22MNT$ 519.07M
Total AssetsNT$ 2.49BNT$ 2.56BNT$ 973.21MNT$ 522.60MNT$ 539.91M
Total DebtNT$ 3.57MNT$ 604.00KNT$ 1.41MNT$ 2.69MNT$ 949.00K
Net DebtNT$ -1.79BNT$ -1.41BNT$ -738.05MNT$ -452.66MNT$ -518.12M
Total LiabilitiesNT$ 84.34MNT$ 64.26MNT$ 76.09MNT$ 8.10MNT$ 5.54M
Stockholders' EquityNT$ 2.40BNT$ 2.49BNT$ 897.12MNT$ 514.50MNT$ 534.37M
Cash Flow
Free Cash FlowNT$ -118.39MNT$ -38.90MNT$ 397.23MNT$ -34.09MNT$ -65.05M
Operating Cash FlowNT$ -115.53MNT$ -37.67MNT$ 403.57MNT$ -32.95MNT$ -63.47M
Investing Cash FlowNT$ 552.45MNT$ -870.35MNT$ -118.18MNT$ -29.84MNT$ 22.51M
Financing Cash FlowNT$ -19.09MNT$ 1.57BNT$ -1.28MNT$ -929.00KNT$ -932.00K

Currency in TWD

Alar Pharmaceuticals Inc Earnings and Revenue History

-250M0250M500M-30000 %-15000 %0 %15000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Alar Pharmaceuticals Inc Liabilities to Assets

01B2B3B0 %3 %6 %9 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Alar Pharmaceuticals Inc Cash Flow

-1B-500M0500M1B1.5B2B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Alar Pharmaceuticals Inc Forecast EPS vs Actual EPS

-0.8-0.6-0.4-0.200.20.4Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >